BARCELONA, April 22 (Reuters) – The head of the European Medicines Agency, Emer Cooke, said on Wednesday that the EU regulatory review of the first of a new generation of weight-loss pills would be concluded this summer.
Cooke, speaking at the Reuters Pharma Europe 2026 event in Barcelona, said the review would be finished “very soon”. Denmark’s Novo Nordisk and U.S. rival Eli Lilly have recently launched pills in the United States.
(Reporting by Maggie Fick; Writing by Ludwig Burger; Editing by Louise Heavens)
